GVHD,ACUTE
Clinical trials for GVHD,ACUTE explained in plain language.
Never miss a new study
Get alerted when new GVHD,ACUTE trials appear
Sign up with your email to follow new studies for GVHD,ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to stop deadly transplant complication
Disease control Recruiting nowThis phase 2 trial tests whether a new dosing schedule of anti-thymocyte globulin (ATG), combined with tacrolimus and low-dose methotrexate, can prevent acute graft-versus-host disease (GVHD) in adults aged 18-60 receiving a stem cell transplant for blood cancers like leukemia. T…
Matched conditions: GVHD,ACUTE
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 24, 2026 05:50 UTC
-
New hope for stem cell transplant patients: combo therapy targets severe GVHD
Disease control Recruiting nowThis study tests whether adding ruxolitinib to standard steroids works better than steroids alone for grade II acute graft-versus-host disease (GVHD), a common complication after stem cell transplant. About 168 adults who have had a first stem cell transplant for blood cancer and…
Matched conditions: GVHD,ACUTE
Phase: PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New hope for stem cell transplant patients with severe GVHD
Disease control Recruiting nowThis study tests whether adding the drug ruxolitinib to standard steroids works better than steroids alone for treating severe graft-versus-host disease (GVHD) after a stem cell transplant. About 54 adults who develop severe GVHD within 100 days of their first transplant will tak…
Matched conditions: GVHD,ACUTE
Phase: PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Simple blood test may predict deadly transplant complication
Diagnosis Recruiting nowThis study is testing whether two blood markers, CXCL9 and EASIX, can predict severe acute graft-versus-host disease (GVHD) in people who have had a stem cell transplant for blood cancer. Researchers will take a blood sample 28 days after transplant and check these markers. The g…
Matched conditions: GVHD,ACUTE
Sponsor: Henry Ford Health System • Aim: Diagnosis
Last updated Jun 22, 2026 11:57 UTC